Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |